Tailor DAPT Duration for Patients at High Bleeding Risk

June 2023

You’ll hear debate about shorter dual antiplatelet therapy (DAPT) durations after a stent in acute coronary syndrome (ACS).

The standard has been aspirin PLUS a P2Y12 inhibitor (clopidogrel, prasugrel, ticagrelor) for 12 months...with the option to extend for those with high thrombotic and low bleeding risk.

But mounting evidence suggests that 1 to 3 months of DAPT may be enough for select patients with ACS...such as those with high bleeding risk due to advanced age, prior GI bleeding, or prior intracranial bleeding.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote